Zhang C - Search Results

1

Correction: Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/ GPX4 expression.

Qiao Y, Su M, Zhao H, Liu H, Wang C, Dai X, Liu L, Liu G, Sun H, Sun M, Wang J, Li Z, Fan J, Zhang Q, Li C, Situ F, Xue J, Jia Z, Zhang C, Zhang S, Shan C. Qiao Y, et al. Among authors: zhang c, zhang s, zhang q. J Exp Clin Cancer Res. 2024 May 2;43(1):131. doi: 10.1186/s13046-024-03051-6. J Exp Clin Cancer Res. 2024. PMID: 38693552 Free PMC article. No abstract available.

2

Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis.

Guo J, Xue Q, Liu K, Ge W, Liu W, Wang J, Zhang M, Li QY, Cai D, Shan C, Zhang C, Liu X, Li J. Guo J, et al. Among authors: zhang m, zhang c. Front Oncol. 2019 Oct 2;9:993. doi: 10.3389/fonc.2019.00993. eCollection 2019. Front Oncol. 2019. PMID: 31632919 Free PMC article.

3

FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1.

Wang J, Qiao Y, Sun M, Sun H, Xie F, Chang H, Wang Y, Song J, Lai S, Yang C, Li X, Liu S, Zhao X, Ni K, Meng K, Zhang S, Shan C, Zhang C. Wang J, et al. Among authors: zhang s, zhang c. Clin Transl Med. 2022 Mar;12(3):e772. doi: 10.1002/ctm2.772. Clin Transl Med. 2022. PMID: 35297218 Free PMC article. No abstract available.

4

A rational foundation for micheliolide-based combination strategy by targeting redox and metabolic circuit in cancer cells.

Guo J, Liu K, Wang J, Jiang H, Zhang M, Liu Y, Shan C, Hu F, Fu W, Zhang C, Li J, Chen Y. Guo J, et al. Among authors: zhang m, zhang c. Biochem Pharmacol. 2022 Jun;200:115037. doi: 10.1016/j.bcp.2022.115037. Epub 2022 Apr 12. Biochem Pharmacol. 2022. PMID: 35427571

5

PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1.

Xie F, Zhang H, Zhu K, Jiang CS, Zhang X, Chang H, Qiao Y, Sun M, Wang J, Wang M, Tan J, Wang T, Zhao L, Zhang Y, Lin J, Zhang C, Liu S, Zhao J, Luo C, Zhang S, Shan C. Xie F, et al. Among authors: zhang c, zhang s, zhang h, zhang x, zhang y. MedComm (2020). 2023 Mar 28;4(2):e245. doi: 10.1002/mco2.245. eCollection 2023 Apr. MedComm (2020). 2023. PMID: 36999124 Free PMC article.

6

Marsdenia tenacissima enhances immune response of tumor infiltrating T lymphocytes to colorectal cancer.

Yi B, Zhang S, Yan S, Liu Y, Feng Z, Chu T, Liu J, Wang W, Xue J, Zhang C, Wang Y. Yi B, et al. Among authors: zhang s, zhang c. Front Immunol. 2023 Aug 15;14:1238694. doi: 10.3389/fimmu.2023.1238694. eCollection 2023. Front Immunol. 2023. PMID: 37649480 Free PMC article.

7

The dysfunctional Wnt pathway down-regulates MLH1/SET expression and promotes microsatellite instability and immunotherapy response in colorectal cancer.

Wang J, He T, Gao Q, Chang H, Dai X, Yang J, Liu S, Zhang S, Shan C, Zhang C. Wang J, et al. Among authors: zhang s, zhang c. Genes Dis. 2023 Apr 28;11(2):542-545. doi: 10.1016/j.gendis.2023.03.026. eCollection 2024 Mar. Genes Dis. 2023. PMID: 37692497 Free PMC article. No abstract available.

8

Transcriptome analysis identifies genetic risk markers and explores the pathogenesis for inflammatory bowel disease.

Wang J, Sun M, Liu X, Yan Q, Gao Q, Ni K, Yang J, Zhang S, Zhang C, Shan C. Wang J, et al. Among authors: zhang s, zhang c. Biochim Biophys Acta Mol Basis Dis. 2024 Mar;1870(3):167013. doi: 10.1016/j.bbadis.2023.167013. Epub 2024 Jan 8. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 38199515

9

Andrographolide sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the EGFR/AKT and PDGFRβ/AKT signaling pathways.

Liu YF, Feng ZQ, Chu TH, Yi B, Liu J, Yu H, Xue J, Wang YJ, Zhang CZ. Liu YF, et al. Phytomedicine. 2024 Apr;126:155462. doi: 10.1016/j.phymed.2024.155462. Epub 2024 Feb 16. Phytomedicine. 2024. PMID: 38394734

10

Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11/GPX4 expression.

Qiao Y, Su M, Zhao H, Liu H, Wang C, Dai X, Liu L, Liu G, Sun H, Sun M, Wang J, Li Z, Fan J, Zhang Q, Li C, Situ F, Xue J, Jia Z, Zhang C, Zhang S, Shan C. Qiao Y, et al. Among authors: zhang c, zhang s, zhang q. J Exp Clin Cancer Res. 2024 Apr 10;43(1):108. doi: 10.1186/s13046-024-03032-9. J Exp Clin Cancer Res. 2024. PMID: 38600610 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,992 results

Search Page

Filters